Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06VTI
|
||||
Drug Name |
Macrocycle derivative 1
|
||||
Synonyms |
PMID30107136-Compound-Example65
|
||||
Drug Type |
Small molecule immunotherapy
|
||||
Indication | Hepatitis [ICD-11: DB97.Z] | Patented | [1] | ||
Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Patented | [1] | |||
Infectious disease [ICD-11: 1A00-CA43.1; ICD-10: A00-B99; ICD-9: 001-139] | Patented | [1] | |||
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Patented | [1] | |||
Company |
Bristol-Myers Squibb Company
|
||||
Structure |
![]() |
||||
Target and Pathway | |||||
Target(s) | CD80-PD-L1 interaction (CD80/PD-L1 PPI) | Target Info | Inhibitor | [1] | |
PD-1-PD-L1 interaction (PD-1/PD-L1 PPI) | Target Info | Inhibitor | [1] | ||
Target's Patent Info | CD80-PD-L1 interaction (CD80/PD-L1 PPI) | Target's Patent Info | [1] | ||
PD-1-PD-L1 interaction (PD-1/PD-L1 PPI) | Target's Patent Info | [1] | |||
References | |||||
REF 1 | A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018).Expert Opin Ther Pat. 2018 Sep;28(9):665-678. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.